New Delhi, Drug firms Unichem Pharmaceuticals and Macleods Pharma are recalling various lots of tablets used for treatment of high blood pressure and diabetes from the...
The audit of Dr. Reddy’s Laboratories Ltd’s Formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US FDA, has been completed today with zero observation....
US FDA has completed inspection of the facility in Gagillapur located in Hyderabad, Telangana, India on 14th February 2020 with two observations. Granules India Limited will...
Panacea Biotec Limited (“the Company”), amongst India’s leading Biotechnology companies announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December...
Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the third quarter ended December 31 of the financial year 2019-20....
Hyderabad: mfine-an artificial intelligence enabled, on-demand healthcare company, has launched ‘Remote Clinics’ an initiative to bring hospital’s satellite or nodal centres, corporate clinic outposts and diagnostic health...
Drug firm Lupin on Wednesday said the US health regulator has issued two observations after inspection of the company”s Madhya Pradesh facility. The inspection of the...
The Indian domestic medical device manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 7.5 percent until 2025, according to GlobalData. The...
Zydus Cadila has received the final approval from the USFDA to market Mesalamine Suppositories for rectal use, (US RLD – Canasa) 1000 mg. The drug is...
Granules India Limited announced today that the US Food & Drug Administration (US FDA) has tentatively approved its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release...
Sun Pharma Advanced Research Company (SPARC) on Tuesday said the US health regulator has not approved its new drug application for Taclantis, its under development product for...
Dr Reddy’s Laboratories on Wednesday announced an agreement with Wockhardt Ltd. to acquire select divisions of its branded generics business in India, Nepal, Sri Lanka, Bhutan and Maldives...
Drug firm Lupin on Wednesday said the US health regulator has issued two observations after inspection of the company’s Madhya Pradesh facility. The inspection of the...
The coronavirus outbreak has exposed India’s vulnerability when it comes to sourcing crucial raw materials for medicines from China, which meets about 70 per cent of the country’s...
Marksans Pharma Ltd has received Establishment Inspection Report (EIR) from the US FDA in respect of inspection of Company’s manufacturing facility Time-Cap Laboratories Inc. located at...
Copyright © 2025 Medical Buyer maintained by Fullstack development